Skip to main content

ABN AMRO INVESTMENT SOLUTIONS

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2080520 PARIS CEDEX 008, I0

Position in REGN

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$3,812,323
+$57,293 QoQ
Shares Held
6,114
+25.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#419
of 1,322 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $84,184,851 across 9 Biotechnology names. REGN ranks #4 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
6,114 $3,812,323

All Filings in REGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,812,323 6,114
2026-03-31 $3,755,030 4,860
2025-12-31 $3,363,037 4,357
2025-09-30 $3,814,439 6,784
2025-06-30 $4,009,950 7,638
2025-03-31 $22,033,150 34,740
2024-12-31 $26,623,333 37,375
2024-09-30 $41,103,484 39,100
2024-06-30 $39,890,792 37,954
2024-03-31 $38,913,470 40,430
2023-12-31 $21,385,483 24,349
2023-09-30 $18,498,494 22,478
2023-06-30 $15,820,813 22,018
2023-03-31 $14,166,412 17,241